Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02TOS
|
||||
| Former ID |
DNC000207
|
||||
| Drug Name |
AMSH
|
||||
| Indication | Female sexual dysfunction [ICD9: 302.7; ICD10:F52] | Investigative | [1] | ||
| Target and Pathway | |||||
| Target(s) | Melanocortin-4 receptor | Target Info | Agonist | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| Pathway Interaction Database | Syndecan-3-mediated signaling events | ||||
| Reactome | Peptide ligand-binding receptors | ||||
| G alpha (s) signalling events | |||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
| Peptide GPCRs | |||||
| GPCR ligand binding | |||||
| GPCR downstream signaling | |||||
| References | |||||
| REF 1 | Designing drugs for the treatment of female sexual dysfunction. Drug Discov Today. 2007 Sep;12(17-18):757-66. Epub 2007 Aug 27. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.